Merck & Co. Hits Target With Pneumococcal Vaccine, As Rivalry With Pfizer Continues

 
• By Alaric DeArment
  
Merck announced positive results for its pneumococcal disease vaccine, V116 • Source: Shutterstock

More from Anti-infective

More from Therapy Areas